FP
LMAT icon

Foundry Partners’s LeMaitre Vascular LMAT Stock Holding History

Foundry Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-39,426
Closed -$1.92M – 404
2021
Q1 		$1.92M Sell
39,426
-18,125
-31% -$849K 0.06% 286
2020
Q4 		$2.33M Sell
57,551
-270
-0.5% -$9.65K 0.09% 262
2020
Q3 		$1.88M Sell
57,821
-37,912
-40% -$1.14M 0.09% 258
2020
Q2 		$2.53M Sell
95,733
-30,656
-24% -$801K 0.12% 214
2020
Q1 		$3.15M Buy
126,389
+9,078
+8% +$280K 0.18% 165
2019
Q4 		$4.22M Buy
+117,311
New +$4.05M 0.16% 191

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Foundry Partners's LMAT Position: Q2 2021 in Review

Foundry Partners sold out of LeMaitre Vascular (LMAT) in Q2 2021, closing a stake of 39,426 shares — an estimated $1.92M sold.

Foundry Partners first reported a position in LMAT in Q4 2019 and held it in 6 quarters. The position peaked at $4.22M in Q4 2019. 185 funds tracked by Wall St. Rank hold LMAT as of Q2 2021.

  • Foundry Partners reported no remaining LeMaitre Vascular position as of Q2 2021 after selling out during the quarter.
  • Foundry Partners sold 39,426 LeMaitre Vascular shares in Q2 2021, an estimated $1.92M.
  • Foundry Partners first reported a position in LeMaitre Vascular in Q4 2019 and held it in 6 quarters.
  • Foundry Partners's LeMaitre Vascular position peaked at $4.22M in Q4 2019.
  • 185 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2021.

Based on Foundry Partners's 13F filing for Q2 2021, filed 23 Jul 2021.